Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-12-012152
Filing Date
2012-02-23
Accepted
2012-02-23 16:18:14
Documents
1
Period of Report
2012-02-23

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 33883
  Complete submission text file 0001104659-12-012152.txt   36034
Mailing Address LICHTSTRASSE 35 CH-4002 BASEL V8
Business Address LICHTSTRASSE 35 CH-4002 BASEL V8 212-830-2474
NOVARTIS PHARMA AG (Reporting) CIK: 0001030617 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-49839 | Film No.: 12634101

Mailing Address 60 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address 60 HAMPSHIRE STREET CAMBRIDGE MA 02139 617-995-9800
IDENIX PHARMACEUTICALS INC (Issuer) CIK: 0001093649 (see all company filings)

EIN.: 450478605 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Reporting) CIK: 0001114448 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-49839 | Film No.: 12634100
SIC: 2834 Pharmaceutical Preparations